https://www.acplgroupindia.in
91

7.53.3 Status identification The manufacturer shall identify the product status with respe...

View more

1.8 Domestic price of the device in the currency followed in the country of origin. 1.9 L...

View more

Clinical investigation team Briefly describe the administrative structure of the clinical ...

View more

CLINICAL INVESTIGATION REPORT 1. General This table specifies the contents of the clinical...

View more

INFORMED CONSENT FORM 1. Checklist for clinical investigation Subject's informed consent ...

View more

Presentation of individual case histories: This section of PSUR shall include the individu...

View more

Status identification The manufacturer shall identify the product status with respect to m...

View more

6. However, accelerated approval should be used for a drug that represent significant adva...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

Subscribe for latest offers and updates.

we hate spam too